Focus
Pharma Investors: Angels and VC Firms
The RaiseHunt database lists 3,592 Pharma investors: 100 angel investors and 3,492 people at 1,040 firms. Most list Seed and Series A among their stages; the largest hubs are New York, London and Paris.
- 3,592
- Pharma investors
- 100
- Angel investors
- 3,492
- People at VC/PE firms
- 1,040
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
3,592 Pharma investors
Showing 101-120
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Pau Fernandez Guirao Partner at Itnig | Cabrils, Spain | AcceleratorVenture capital | AIHealthcare | ||
 Victor Rusu Principal at MPM BioImpact | Boston, United States | Private equityVenture capital | Healthcare | ||
 Mira Chaurushiya Managing Director at Westlake BioPartners® | San Francisco, United States | AcceleratorSyndicate / Angel group | FinTechHardware | ||
 Charles Kunsch Venture Partner at Dreavent | Boston, United States | Venture capital | Healthcare | ||
 Parag Shah CEO & Founding Managing Director at K2 HealthVentures | Boston, United States | AcceleratorPrivate equity | AIHealthcare | ||
 Angad Bhandari Principal at TPG | Mumbai, India | Private equityVenture debt | AIFinTech | ||
 Daniela Couto General Partner at Bgv (biogeneration Ventures) | Netherlands | Venture capital | Healthcare | ||
 Carla Daniel Partner & Chief People Officer at The Column Group | San Francisco, United States | Venture capital | Healthcare | ||
 Alim Ladha Research and Investments at Royalty Pharma | New York, United States | Private equityVenture debt | Healthcare | ||
 Colin Hill Member of the Board of Directors at PPD | Cambridge, United States | Corporate VC | Healthcare | ||
 Kush Parmar Managing Partner at 5AM Ventures | Boston, United States | Venture capital | Healthcare | ||
 Mudasser Zaheer SVP and Chief Information Officer at McKesson | Houston, United States | Corporate VC | Healthcare | ||
 Rebecca Soulsby Principal at TPG | Sydney, Australia | Private equityVenture debt | AIFinTech | ||
 Dapo Ogunfeitimi Investor at Wellington Management | New York City, United States | Private equityVenture debt | AIClimate | ||
 Evan Wildstein Partner at Kohlberg Ventures | Mount Kisco, United States | Private equity | ConsumerHardware | ||
 Weini Zhang Private Equity Investor at CapVest | London, United Kingdom | Private equity | ConsumerFinTech | ||
 Jean Roberts Investment Partner at Kohlberg Ventures | New York, United States | Private equity | ConsumerHardware | ||
 Nicole Schlanger Affiliated at Gilead Group | St Louis, United States | Family Office | Healthcare | ||
 Merijn Klaassen CFO & COO EQT Life Sciences (formerly LSP) at Eqt Life Sciences | Tilburg, Netherlands | Private equityVenture capital | Healthcare | ||
 Jeffrey Glushakow Investor at Wuxi Biologics | London, United Kingdom | Corporate VC | Healthcare |
Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal